Keep checking back for new content

Treatments

Age-related risks of radical prostatectomy

January 22, 2019

It will hardly come as a surprise to most prostate cancer support group leaders and other prostate cancer advocates that there is a strong association between patient age and risk for side effects of radical prostatectomy. However, we now have a rather more sophisticated set of insight into such risks. Read the article.

Read the article or watch the video →

Complementary Therapies for Prostate Cancer Treatment

December 31, 2018

Today, more and more complementary therapies are being integrated into care plans for patients with prostate cancer. Read the article here.

Read the article or watch the video →

Active Surveillance for Intermediate Risk Prostate Cancer: Survival Outcomes in the Sunnybrook Experience.

December 31, 2018

Data from the survival outcomes of patients support the use of active surveillance in low risk and intermediate risk cases of Gleason 6 but not Gleason 7 prostate cancer. Multiparametric magnetic resonance imaging and novel biomarkers might be vital in detecting favorable Gleason 7 disease. Read the article here.

Read the article or watch the video →

Magnetic resonance spectroscopy-based method may help predict prostate cancer aggressiveness

December 31, 2018

Metabolic analysis of benign tissue samples from men with prostate cancer allowed researchers to retrospectively predict the aggressiveness of disease and likelihood of recurrence, according to study results. Read the article here.

Read the article or watch the video →

Long-term Outcomes of Active Surveillance for Prostate Cancer – The Memorial Sloan Kettering Cancer Center Experience

December 31, 2018

A presentation of the Memorial Sloan Kettering Cancer Center experience with active surveillance over a long-term follow-up. Read the article here.

Read the article or watch the video →

Brachytherapy: Is It the Best Option for Your Prostate Cancer?

December 31, 2018

An outpatient procedure worthy of note is brachytherapy, which involves placing radioactive sources within your tumor to destroy the cancerous cells. Read the article here.

Read the article or watch the video →

Canadian lab takes a shot at producing cancer-killing treatment dubbed the ‘rarest drug on Earth’

September 16, 2018

Canada’s particle physics laboratory TRIUMF is making a push to be a future world leader in the production of a special radioactive isotope nicknamed the “rarest drug on Earth,” which can deliver devastating amounts of energy to single cancer cells, without harming nearby tissue. Read the article here.

Read the article or watch the video →

When Can Patients With Gleason 6 Prostate Cancer Safely Undergo Active Surveillance?

September 16, 2018

When Can Patients With Gleason 6 Prostate Cancer Safely Undergo Active Surveillance? A roundtable discussion. Read the article here.

Read the article or watch the video →

Active Surveillance for Intermediate Risk Prostate Cancer

September 16, 2018

Larry Goldenberg, MD demonstrated his support for using active surveillance in intermediate-risk prostate cancer. Read the article here.

Read the article or watch the video →

Statin Use in Prostate Cancer

September 16, 2018

An overview on statin use in prostate cancer. Read the article here.

Read the article or watch the video →